Entrada Therapeutics TRDA
NASDAQ TRDA
$6.26 +0.04 (+0.64%)
At close: Sep 29, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) Total Current Liabilities (2020 - 2026)

Updated

Entrada Therapeutics' Total Current Liabilities came in at $21.37 million for Q2 2026, up 7.9% from $19.8 million a year earlier and up 11.3% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Entrada Therapeutics' Total Current Liabilities was $24.45 million, down 38.1% from FY2024.

  • Total Current Liabilities carries a five-year compound annual growth rate of 48.7% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $39.48 million in FY2024 (-75.1%), $158.8 million in FY2023 (+622.7%), $21.97 million in FY2022 (+227.0%) and $6.72 million in FY2021 (+100.0%).
  • The five-year range for quarterly Total Current Liabilities is $6.72 million (Q4 2021) to $173.94 million (Q1 2024).
  • Year-over-year, Total Current Liabilities increased in two of the last eight quarters, with an average decline of 48.8%.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q1 2023 (growth of 856.8%), and the weakest in Q1 2025 (a decline of 89.4%).
  • Business Quant data shows TRDA's Total Current Liabilities at $19.2 million (Q1 2026), $24.45 million (Q4 2025) and $24.02 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Entrada Therapeutics 242.19 Mn 242.19 Mn - 21.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.37 Mn
Mar 31, 2026 19.20 Mn
Dec 31, 2025 24.45 Mn
Sep 30, 2025 24.02 Mn
Jun 30, 2025 19.80 Mn
Mar 31, 2025 18.43 Mn
Dec 31, 2024 39.48 Mn
Sep 30, 2024 70.60 Mn
Jun 30, 2024 85.81 Mn
Mar 31, 2024 173.94 Mn
Dec 31, 2023 158.80 Mn
Sep 30, 2023 165.43 Mn
Jun 30, 2023 125.94 Mn
Mar 31, 2023 147.59 Mn
Dec 31, 2022 21.97 Mn
Sep 30, 2022 21.55 Mn
Jun 30, 2022 18.08 Mn
Mar 31, 2022 15.43 Mn
Dec 31, 2021 6.72 Mn
Sep 30, 2021 7.16 Mn
API Access

Entrada Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TRDA&period=max&api_key=YOUR_API_KEY